A SECRET WEAPON FOR WHO MAKES THE DIABETES DRUG COPYRIGHT

Novo Nordisk's pricing approaches within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, stating the stark distinction among U.S. rates and those in Europe and copyright.This led Novo Nordisk to carry out even more investigation into greater dosages of semaglutide especially fo